Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy
The purpose of this study is to assess changes of bone mineral density (BMD) at 12 months during the therapeutic management of patients with lymphoma.
Lymphoma|Osteoporosis
RADIATION: Bone densitometry.
Measurement of bone mineral density (BMD)., Patients will have a review of bone densitometry., Change from Baseline of bone mineral density at 12 months.
The purpose of this study is to assess changes of bone mineral density (BMD) at 12 months during the therapeutic management of patients with lymphoma.